Zimmer Biomet Holdings Financial Statements (ZBH)
|
|
|
|
Report date
|
|
|
31.12.2022 |
24.02.2023 |
23.02.2024 |
25.02.2025 |
20.02.2026 |
|
01.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
6 940 |
6 940 |
7 394 |
7 679 |
8 232 |
|
8 409 |
|
Operating Income, bln rub |
|
|
696.3 |
696.3 |
1 278 |
1 286 |
1 362 |
|
1 312 |
|
EBITDA, bln rub |
? |
|
1 495 |
1 495 |
2 220 |
2 251 |
2 217 |
|
2 206 |
|
Net profit, bln rub |
? |
|
291.2 |
231.4 |
1 024 |
903.8 |
705.2 |
|
761.3 |
|
|
OCF, bln rub |
? |
|
1 356 |
1 285 |
1 582 |
1 499 |
1 697 |
|
1 673 |
|
CAPEX, bln rub |
? |
|
187.9 |
217.6 |
394.5 |
356.8 |
224.5 |
|
394.9 |
|
FCF, bln rub |
? |
|
1 168 |
1 067 |
1 187 |
1 143 |
1 473 |
|
1 836 |
|
Dividend payout, bln rub
|
|
|
201.2 |
201.2 |
200.9 |
196.0 |
190.3 |
|
189.4 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
69.1% |
86.9% |
19.6% |
21.7% |
27.0% |
|
24.9% |
|
|
OPEX, bln rub |
|
|
4 224 |
4 224 |
4 033 |
4 202 |
3 710 |
|
4 577 |
|
Cost of production, bln rub |
|
|
2 020 |
2 020 |
2 084 |
2 191 |
3 160 |
|
2 520 |
|
R&D, bln rub |
|
|
406.0 |
406.0 |
458.7 |
437.4 |
458.5 |
|
451.4 |
|
Interest expenses, bln rub |
|
|
164.8 |
164.8 |
201.2 |
218.0 |
292.8 |
|
295.4 |
|
|
Assets, bln rub |
|
|
21 066 |
21 066 |
21 497 |
21 365 |
23 092 |
|
22 722 |
|
Net Assets, bln rub |
? |
|
12 027 |
12 020 |
12 481 |
12 468 |
12 706 |
|
14 738 |
|
Debt, bln rub |
|
|
5 697 |
5 697 |
5 768 |
6 205 |
7 519 |
|
7 471 |
|
Cash, bln rub |
|
|
375.7 |
375.7 |
415.8 |
525.5 |
591.9 |
|
424.2 |
|
Net debt, bln rub |
|
|
5 321 |
5 321 |
5 352 |
5 679 |
6 927 |
|
7 047 |
|
|
Ordinary share price, rub |
|
|
127.5 |
127.5 |
121.7 |
105.6 |
89.9 |
|
83.4 |
|
Number of ordinary shares, mln |
|
|
209.6 |
209.6 |
208.7 |
203.1 |
198.0 |
|
195.0 |
|
|
Market cap, bln rub |
|
|
26 724 |
26 724 |
25 399 |
21 453 |
17 804 |
|
16 265 |
|
EV, bln rub |
? |
|
32 045 |
32 045 |
30 751 |
27 133 |
24 731 |
|
23 312 |
|
Book value, bln rub |
|
|
-1 617 |
-1 624 |
-1 194 |
-1 081 |
-1 959 |
|
259 |
|
|
EPS, rub |
? |
|
1.39 |
1.10 |
4.91 |
4.45 |
3.56 |
|
3.90 |
|
FCF/share, rub |
|
|
5.57 |
5.09 |
5.69 |
5.63 |
7.44 |
|
9.41 |
|
BV/share, rub |
|
|
-7.71 |
-7.75 |
-5.72 |
-5.32 |
-9.89 |
|
1.33 |
|
|
EBITDA margin, % |
? |
|
21.5% |
21.5% |
30.0% |
29.3% |
26.9% |
|
26.2% |
|
Net margin, % |
? |
|
4.20% |
3.33% |
13.8% |
11.8% |
8.57% |
|
9.05% |
|
FCF yield, % |
? |
|
4.37% |
3.99% |
4.67% |
5.33% |
8.27% |
|
11.3% |
|
ROE, % |
? |
|
2.42% |
1.93% |
8.20% |
7.25% |
5.55% |
|
5.17% |
|
ROA, % |
? |
|
1.38% |
1.10% |
4.76% |
4.23% |
3.05% |
|
3.35% |
|
|
P/E |
? |
|
91.8 |
115.5 |
24.8 |
23.7 |
25.2 |
|
21.4 |
|
P/FCF |
|
|
22.9 |
25.0 |
21.4 |
18.8 |
12.1 |
|
8.86 |
|
P/S |
? |
|
3.85 |
3.85 |
3.43 |
2.79 |
2.16 |
|
1.93 |
|
P/BV |
? |
|
-16.5 |
-16.5 |
-21.3 |
-19.8 |
-9.09 |
|
62.9 |
|
EV/EBITDA |
? |
|
21.4 |
21.4 |
13.9 |
12.1 |
11.2 |
|
10.6 |
|
Debt/EBITDA |
|
|
3.56 |
3.56 |
2.41 |
2.52 |
3.12 |
|
3.19 |
|
|
R&D/CAPEX, % |
|
|
216.1% |
186.6% |
116.3% |
122.6% |
204.2% |
|
114.3% |
|
|
CAPEX/Revenue, % |
|
|
2.71% |
3.14% |
5.34% |
4.65% |
2.73% |
|
4.70% |
|
| Zimmer Biomet Holdings shareholders |
